2016 Annual Meeting | Pain and Palliative Care
| 04:45 PM - 05:30 PM | Abstract |
002 - Ethical Conflicts at the End of Life in Patients with Malignant Brain Tumors
Eli Diamond, MD |
| 04:45 PM - 05:30 PM | Abstract |
003 - Tetrodotoxin (TTX) for Chemotherapy Induced Neuropathic Pain (CINP): A Randomized, Double-Blind, Dose-Finding, Placebo Controlled, Multicenter Study
Samuel Goldlust, MD |
| Misha-Miroslav Backonja, MD | Dr. Backonja has nothing to disclose. |
| John Markman, MD, FAAN | Dr. Markman has received personal compensation for serving as an employee of Eli LIlly. |
| Alan C. Carver, MD | No disclosure on file |
| Elizabeth C. Neil, MD | No disclosure on file |
| Samuel Goldlust, MD | No disclosure on file |
| Walter N. Korz | No disclosure on file |
| No disclosure on file | |
| Mehran Kavoosi | No disclosure on file |
| Eli Diamond, MD | Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Biopharmaceuticals. Dr. Diamond has received research support from Applebaum Foundation. Dr. Diamond has received research support from Frame Family Fund. Dr. Diamond has received research support from Joy Family West Foundation. |